Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108128
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Umberto Veronesi
This publication has 27 references indexed in Scilit:
- Adjunctive lacosamide—5 Years’ clinical experienceEpilepsy Research, 2014
- Treatment outcome after failure of a first antiepileptic drugNeurology, 2014
- Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical‐controlled, multicenter, double‐blind studyEpilepsia, 2014
- Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: An Italian multicenter prospective observational studyEpilepsy & Behavior, 2013
- Adjunctive lacosamide in clinical practice: Sodium blockade with a difference?Epilepsy & Behavior, 2011
- A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic DrugsCNS Drugs, 2010
- Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trialEpilepsia, 2010
- Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trialEpilepsia, 2009
- Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset SeizuresEpilepsia, 2007
- Epilepsy after the first drug fails: substitution or add-on?Seizure: European Journal of Epilepsy, 2000